Ranking · Winter 2016 · Healthcare · Drug Discovery and Delivery

Perlara

Perlara: building the YC for rare disease parents

5.6%

odds of being acquired in the next two years

0.8× the average (6.8%)

#3027 of 4,339 active YC companies · top 71%

Team of 1 · San Francisco, CA, USA; Oakland, CA, USA; Remote

Raises the odds

↑ based in Fully Remote

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

Lowers the odds

↓ team of 1–2

↓ industry: Healthcare

↓ “building” in its one-liner

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Perlara's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

perlara.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub